2-167135972-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_152381.6(XIRP2):c.472G>A(p.Glu158Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0198 in 1,611,940 control chromosomes in the GnomAD database, including 471 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_152381.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XIRP2 | NM_152381.6 | c.472G>A | p.Glu158Lys | missense_variant | 3/11 | ENST00000409195.6 | |
XIRP2-AS1 | NR_046665.1 | n.154+4830C>T | intron_variant, non_coding_transcript_variant | ||||
XIRP2 | NM_001199143.2 | c.472G>A | p.Glu158Lys | missense_variant | 3/11 | ||
XIRP2 | NM_001079810.4 | c.472G>A | p.Glu158Lys | missense_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XIRP2 | ENST00000409195.6 | c.472G>A | p.Glu158Lys | missense_variant | 3/11 | 5 | NM_152381.6 | ||
XIRP2-AS1 | ENST00000525330.1 | n.154+4830C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0154 AC: 2346AN: 152088Hom.: 33 Cov.: 32
GnomAD3 exomes AF: 0.0189 AC: 4687AN: 247404Hom.: 80 AF XY: 0.0214 AC XY: 2879AN XY: 134296
GnomAD4 exome AF: 0.0202 AC: 29534AN: 1459734Hom.: 437 Cov.: 30 AF XY: 0.0215 AC XY: 15646AN XY: 726176
GnomAD4 genome AF: 0.0154 AC: 2344AN: 152206Hom.: 34 Cov.: 32 AF XY: 0.0149 AC XY: 1109AN XY: 74404
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at